大型社区队列中儿童葡萄膜炎的缓解发生率及预测因素
该回顾性临床队列研究纳入2010年1月1日至2020年12月31日在Kaiser Permanente北加州新诊断的16岁及以下葡萄膜炎患者,共识别277例非感染性葡萄膜炎,其中145例慢性非感染性葡萄膜炎接受至少3个月治疗。5年随访时无药缓解累积概率为50.8%(95%CI=41.7%-60.6%),开始治疗时年龄较大(aHR=1.18,95%CI=1.1-1.28)和男性(aHR=1.85,95%CI=1.11-3.08)与更高的缓解发生率相关。
要点
- 慢性非感染性葡萄膜炎患儿5年无药缓解累积概率为50.8%(95%CI=41.7%-60.6%)。
- 开始治疗时年龄较大(aHR=1.18,95%CI=1.1-1.28)和男性(aHR=1.85,95%CI=1.11-3.08)与缓解发生率较高相关。
- 女性性别和初诊年龄较小是儿童葡萄膜炎缺乏缓解的独立预测因素。
核心结论
- 近半数新诊断的慢性非感染性葡萄膜炎儿童在5年随访内实现无药缓解,年龄最小者最不可能缓解,年龄最大者最可能缓解。
- 女性性别和初诊年龄较小是儿童葡萄膜炎缺乏缓解的独立预测因素。
研究设计与样本
- 回顾性临床队列研究,纳入2010年1月1日至2020年12月31日在Kaiser Permanente北加州新诊断的16岁及以下葡萄膜炎患者,数据从医疗记录、药房记录和健康计划数据库电子提取,采用Cox回归模型和生存分析确定发生率和预测因素。
主要发现
- 共识别1643例新发葡萄膜炎患者中的277例非感染性葡萄膜炎,其中145例(52.3%)为接受至少3个月治疗的慢性非感染性葡萄膜炎。
- 145例慢性非感染性葡萄膜炎中,75例(51.7%)为女性,102例(70.3%)为前葡萄膜炎,开始治疗时平均年龄9.8岁(SD=4.31),平均随访41.3个月(SD=31.8)。
- 5年随访时无药缓解累积概率为50.8%(95%CI=41.7%-60.6%)。
- 开始治疗时年龄(aHR=1.18,95%CI=1.1-1.28)和男性(aHR=1.85,95%CI=1.11-3.08)与更高的缓解发生率相关。
- 未达显著性的基线特征包括双眼疾病、前葡萄膜炎、后粘连、白内障、幼年特发性关节炎、视力、烟草暴露和社会经济状态;随就诊年龄增加可见剂量-反应生存效应。
关键数值与推荐
- 主要结局指标为无药缓解发生率,主要分析中缓解定义为停止药物效应后至少3个月无活动性葡萄膜炎复发。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To describe a large community cohort of incident cases of childhood uveitis and to determine incidence and predictors of remission. DESIGN: Retrospective clinical cohort study. METHODS: Participants were patients aged 16 years or younger who were newly diagnosed with uveitis at Kaiser Permanente Northern California, a large integrated health care system, between January 1, 2010, and December 31, 2020. Data were extracted electronically from medical records, pharmacy records, and health plan database. Incidence and predictors were determined using Cox regression modeling and survival analysis. The main outcome measure was the incidence of drug-free remission. For the primary analysis, remission was defined as no recurrence of active uveitis for at least 3 months beyond cessation of drug effect. Factors potentially predictive of remission were assessed. RESULTS: Of 1643 patients with incident uveitis, 277 incident cases of noninfectious uveitis were identified, including 145 patients (52.3%) with chronic noninfectious uveitis who were treated for at least 3 months; of these, 75 patients (51.7%) were female and 102 patients (70.3%) had anterior uveitis. Mean age at initial treatment was 9.8 (SD = 4.31) years. Mean follow-up time was 41.3 (SD = 31.8) months. At 5-year follow-up, the cumulative probability of drug-free remission was 50.8% (95% CI = 41.7%-60.6%). Age at start of treatment (adjusted hazard ratio [aHR] = 1.18. 95% CI = 1.1-1.28) and male sex (aHR = 1.85; 95% CI = 1.11-3.08) were associated with higher incidence of remission. Baseline characteristics that did not reach significance included bilateral disease, anterior uveitis, posterior synechiae, cataract, juvenile idiopathic arthritis, visual acuity, tobacco exposure, and socioeconomic status. A dose-response survival effect was seen with increasing age at presentation. CONCLUSIONS: Almost half of the children with newly diagnosed chronic noninfectious uveitis achieved drug-free remission within 5 years of follow-up, with the youngest least likely to achieve remission and the oldest most likely to achieve remission. Female sex and younger age at presentation were independent predictors of lack of remission of childhood uveitis.
引用
- Qian Y, Xu RH, Rabbani JW, et al. Incidence and Predictors of Remission of Childhood Uveitis in a Large Community Cohort. Am J Ophthalmol. 2025. PMID: 40449643. doi:10.1016/j.ajo.2025.05.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。